Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones
A technology of methylpyridoxine and its extract, which is applied in food preparation, medical raw materials derived from ginkgo biloba, drug combination, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0066] Example 1: Ginkgo biloba extract with reduced content of 4'-O-methylpyridoxine
[0067] 1249g of the extract solution obtained according to the above preparation method was adjusted with water until the ethanol content was about 40% (w / w) and applied to 50ml (corresponding to 0.28ml per gram of dry extract) Amberlite IR-120 (strongly acidic ion exchanger) ) (Tubular column: about 2×16.5 cm; flow rate: about 8 ml / min) (step I)), followed by flushing with 200 ml of 50% ethanol (w / w). The resulting solution was concentrated on a rotary evaporator and dried in vacuum at 50°C (step m)): 179.4 g.
[0068] It can be seen from the following table that the content of 4'-O-methylpyridoxine of 0.4 ppm is achieved without basically changing the content of the components related to the efficacy.
example 2
[0071] Example 2a): Ginkgo biloba extract with reduced content of diflavonoids
[0072] 500g of the extract solution obtained according to the above preparation method was adjusted with water until the ethanol content was about 40% (w / w) and applied to 400ml (corresponding to 5.7ml per gram of dry extract) Sepabeads SP-850 (adsorbent resin) ( Column: about 4×32 cm; flow rate: about 8 ml / min) (step 1)), followed by flushing with a total of about 2 liters of 40% ethanol (w / w). 10% (259.3 g) of the resulting solution was concentrated on a rotary evaporator and freeze-dried (step m)): 6.92 g. The remaining 90% of the solution was used in Example 2b).
[0073] It can be seen from the following table that the content of diflavonoids of less than 1 ppm is achieved under the condition that the content of the ingredients related to the efficacy is basically unchanged.
example 2
[0074] Example 2b): Ginkgo biloba extract with reduced content of 4'-O-methylpyridoxine and diflavonoids
[0075] 90% (2334.1g) of the solution obtained in Example 2a) was applied to 25ml (corresponding to 0.40ml per gram of dry extract) Amberlite IR-120 (strongly acidic ion exchanger) (column: about 1.5×11cm; Flow rate: about 10ml / min) (step 1)), followed by flushing with 100ml 40% ethanol (w / w). The resulting solution was concentrated on a rotary evaporator and freeze-dried (step m)): 61.67 g.
[0076] It can be seen from the table below that the 4'-O-methylpyridoxine content of 0.4 ppm and the diflavonoid content of less than 1 ppm were achieved under the condition that the content of the components related to the efficacy was basically unchanged.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com